Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a light device for symptoms of autism in young children

Tests a light-based device, compared with a sham device, in children with autism.

Plain-language title generated from the registry record
Registry title: Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

Key facts

Where
New York and Syracuse, United StatesSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 8 years old?

Source: NCT06006637, who can take part

Where in United States

  • Mt Sinai Medical CenterNew York, United StatesTaking people
  • Golisano Center for Special NeedsSyracuse, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
State University of New York - Upstate Medical University
Trial code
NCT06006637
Record updated
14 October 2025
Original description
This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.Read full original descriptionShow less

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.

Inclusion: Ages 2 - 8; Autism spectrum disorder diagnosis; CARS-2 score of 30 - 45.

Exclusion: Taking psychotropic medications; Having implanted devices (including cochlear implants); Having history of seizures; Having history of abnormal EEG; CARS scores less than 30 or over 45; Having skin lesions on scalp; Being a relative of the PI or a researcher.

ClinicalTrials.gov NCT06006637